COVID-19 updates: Remdesivir (Veklury) in high-risk outpatients with COVID-19.

Med Lett Drugs Ther ; 64(1644): 31-32, 2022 02 21.

Article in English | MEDLINE | ID: covidwho-1688500

Subject(s)

Adenosine Monophosphate/analogs & derivatives; Alanine/analogs & derivatives; Antiviral Agents/therapeutic use; COVID-19 Drug Treatment; Adenosine Monophosphate/adverse effects; Adenosine Monophosphate/therapeutic use; Alanine/adverse effects; Alanine/therapeutic use; Antiviral Agents/adverse effects; Clinical Trials as Topic; Humans; SARS-CoV-2

Keywords

COVID-19; Paxlovid; Veklury; dosage; efficacy; nirmatrelvir; remdesivir; ritonavir; sotrovimab

Search on Google

XML

PubMed Links

Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Adenosine Monophosphate / Alanine / COVID-19 Drug Treatment Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Med Lett Drugs Ther Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML

PubMed Links